Your browser doesn't support javascript.
loading
ß-amyloid PET harmonisation across longitudinal studies: Application to AIBL, ADNI and OASIS3.
Bourgeat, Pierrick; Doré, Vincent; Burnham, Samantha C; Benzinger, Tammie; Tosun, Duygu; Li, Shenpeng; Goyal, Manu; LaMontagne, Pamela; Jin, Liang; Rowe, Christopher C; Weiner, Michael W; Morris, John C; Masters, Colin L; Fripp, Jurgen; Villemagne, Victor L.
Afiliación
  • Bourgeat P; CSIRO Health and Biosecurity, Brisbane, Australia. Electronic address: Pierrick.bourgeat@csiro.au.
  • Doré V; CSIRO Health and Biosecurity, Brisbane, Australia; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia.
  • Burnham SC; CSIRO Health and Biosecurity, Brisbane, Australia.
  • Benzinger T; Knight Alzheimer Disease Research Center, St. Louis, MO, USA.
  • Tosun D; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA,; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
  • Li S; CSIRO Health and Biosecurity, Brisbane, Australia.
  • Goyal M; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, USA.
  • LaMontagne P; Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, USA.
  • Jin L; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia.
  • Rowe CC; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia.
  • Weiner MW; San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA,; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.
  • Morris JC; Washington University in St. Louis, St. Louis, MO, USA.
  • Masters CL; The Florey Institute of Neuroscience and Mental Health, University of Melbourne, Parkville, Melbourne, Australia.
  • Fripp J; CSIRO Health and Biosecurity, Brisbane, Australia.
  • Villemagne VL; Department of Molecular Imaging & Therapy, Austin Health, Melbourne, Australia; Department of Psychiatry, The University of Pittsburgh, Pittsburgh, PA, USA.
Neuroimage ; 262: 119527, 2022 11 15.
Article en En | MEDLINE | ID: mdl-35917917
ABSTRACT

INTRODUCTION:

The Centiloid scale was developed to harmonise the quantification of ß-amyloid (Aß) PET images across tracers, scanners, and processing pipelines. However, several groups have reported differences across tracers and scanners even after centiloid conversion. In this study, we aim to evaluate the impact of different pre and post-processing harmonisation steps on the robustness of longitudinal Centiloid data across three large international cohort studies.

METHODS:

All Aß PET data in AIBL (N = 3315), ADNI (N = 3442) and OASIS3 (N = 1398) were quantified using the MRI-based Centiloid standard SPM pipeline and the PET-only pipeline CapAIBL. SUVR were converted into Centiloids using each tracer's respective transform. Global Aß burden from pre-defined target cortical regions in Centiloid units were quantified for both raw PET scans and PET scans smoothed to a uniform 8 mm full width half maximum (FWHM) effective smoothness. For Florbetapir, we assessed the performance of using both the standard Whole Cerebellum (WCb) and a composite white matter (WM)+WCb reference region. Additionally, our recently proposed quantification based on Non-negative Matrix Factorisation (NMF) was applied to all spatially and SUVR normalised images. Correlation with clinical severity measured by the Mini-Mental State Examination (MMSE) and effect size, as well as tracer agreement in 11C-PiB-18F-Florbetapir pairs and longitudinal consistency were evaluated.

RESULTS:

The smoothing to a uniform resolution partially reduced longitudinal variability, but did not improve inter-tracer agreement, effect size or correlation with MMSE. Using a Composite reference region for 18F-Florbetapir improved inter-tracer agreement, effect size, correlation with MMSE, and longitudinal consistency. The best results were however obtained when using the NMF method which outperformed all other quantification approaches in all metrics used.

CONCLUSIONS:

FWHM smoothing has limited impact on longitudinal consistency or outliers. A Composite reference region including subcortical WM should be used for computing both cross-sectional and longitudinal Florbetapir Centiloid. NMF improves Centiloid quantification on all metrics examined.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Enfermedad de Alzheimer Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuroimage Asunto de la revista: DIAGNOSTICO POR IMAGEM Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Péptidos beta-Amiloides / Enfermedad de Alzheimer Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Neuroimage Asunto de la revista: DIAGNOSTICO POR IMAGEM Año: 2022 Tipo del documento: Article